Fast LC-MS electrospray ionization for the quantification of digoxin in human plasma and its application to bioequivalence studies

Chromatographia

Volumn 69, Issue SUPPL. 2, 2009, Pages

  Teixeira, Leonardo S ^a   Mundim, Iram M ^a   Souza, Weidson C ^a   Ramos, Douglas R ^a   Bellorio, Karine B ^a   Marques, Fernanda G ^b   Rezende, Kênnia R ^b  

^a Instituto de Ciencias Farmaceuticas   (Brazil)

^b FEDERAL UNIVERSITY OF GOIÁS   (Brazil)

Author keywords

Bioequivalence and pharmacokinetic study; Column liquid chromatography mass spectrometry; Digoxin; Method validation

Indexed keywords

DEXAMETHASONE; DIGOXIN;

ACCURACY; AREA UNDER THE CURVE; ARTICLE; BIOEQUIVALENCE; CALIBRATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG BLOOD LEVEL; DRUG HALF LIFE; ELECTROSPRAY MASS SPECTROMETRY; FOOD AND DRUG ADMINISTRATION; HIGH THROUGHPUT SCREENING; HUMAN; LIQUID CHROMATOGRAPHY; MAXIMUM PLASMA CONCENTRATION; NORMAL HUMAN; PLASMA; PLASMA CONCENTRATION-TIME CURVE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RANDOMIZED CONTROLLED TRIAL; SENSITIVITY AND SPECIFICITY; SINGLE DRUG DOSE; TIME TO MAXIMUM PLASMA CONCENTRATION; UNITED STATES; VALIDATION PROCESS; VOLUNTEER;

EID: 67651241090     PISSN: 00095893     EISSN: 16121112     Source Type: Journal    
DOI: 10.1365/s10337-009-1014-2     Document Type: Article

References (19)

1. Silva P (2006) Farmacologia. Guanabara Koogan, Rio de Janeiro, pp 63-67, 642
2. S Rathore J Curtis Y Wang M Bristow H Krumholz 2003 JAMA 289 871 878 10.1001/jama.289.7.871 (Pubitemid 37430346)
3. R Pähkla A Irs K Oselin L Rootslane 1999 J Clin Pharm Ther 24 375 380 10.1046/j.1365-2710.1999.00239.x (Pubitemid 29520788)
4. KA Graefe Z Tang HT Karnes 2000 J Chromatogr B Anal Technol Biomed Life Sci 745 305 314 10.1016/S0378-4347(00)00304-2 (Pubitemid 30665555)
5. K Belsner B Büchele 1996 J Chromatogr B Anal Technol Biomed Life Sci 682 95 107 10.1016/0378-4347(96)00056-4 (Pubitemid 26228288)
6. Garteiz D, Din S, Morrow R (2003) Quantification of digoxin in human plasma using negative ion electrospray ionization LC/MS. Varian Inc., Houston
7. A Tracqui P Kintz B Ludes 1997 J Cromatogr. B 692 101 109 10.1016/S0378-4347(96)00462-8 (Pubitemid 27208472)
8. Baselt RC, Cravey RH (1995) Disposition of toxic drugs and chemicals in man. Chemical Toxicology Institute, Foster City, p 802
9. JA Stone SJ Soldin 1989 Clin Chem 35 1326 1331
10. RG Stoll MS Christensen E Sakmar JG Wagner 1972 Res Commun Mol Pathol Pharmacol 4 503 510
11. L Frommherz H Kohler B Brinkmann M Lehr J Beike 2008 Int J Legal Med 122 109 10.1007/s00414-007-0175-5 (Pubitemid 351170118)
12. M Yao H Zhang S Chong M Zhu RA Morrison 2003 J Pharm Biomed Anal 32 1189 10.1016/S0731-7085(03)00050-5 (Pubitemid 36930105)
13. ANVISA, Agência Nacional de Vigilância Sanitária (2003) RE no 899, de 29 de Maio de 2003. Guia para validação de métodos analíticos e bioanalíticos
14. FDA, Center for Drug Evaluation and Research (2001) U S Department of Health and Human Services, Guidance for Industry, Bionalytical Method Validation
15. United States Pharmacopeia Convention (2003) United States pharmacopeia, USP 26. National Publishing, Philadelphia
16. S Bansal A DeStefano 2007 AAPS J 9 E109 E114 10.1208/aapsj0901011 (Pubitemid 46566230)
17. P Zöllner A Leitner D Lubda K Cabrera W Lindner 2000 Chromatographia 52 818 820 10.1007/BF02491011
18. KM Fadden J Gillespie B Carney D O'Driscoll 2006 J Chromatogr A 1120 54 60 10.1016/j.chroma.2006.01.071 (Pubitemid 43866763)
19. A Jedlička T Grafnetterová V Miller 2003 J Chromatogr B Anal Technol Biomed Life Sci 33 109 115